We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
51
Boeing
BA
$165B
$2.51M 0.67%
9,868
-1,567
-14% -$365K
WMT icon
52
Walmart Inc
WMT
$863B
$2.48M 0.66%
95,040
-5,454
-5% -$143K
PEG icon
53
Public Service Enterprise Group
PEG
$39.8B
$2.46M 0.66%
53,224
-2,700
-5% -$122K
VER
54
DELISTED
VEREIT, Inc.
VER
$2.44M 0.65%
58,930
+63
+0.1% +$2.66K
AEP icon
55
American Electric Power
AEP
$73.4B
$2.43M 0.65%
34,565
-1,656
-5% -$118K
SNY icon
56
Sanofi
SNY
$104B
$2.43M 0.65%
48,762
-3,584
-7% -$173K
DUK icon
57
Duke Energy
DUK
$101B
$2.37M 0.63%
28,210
-1,278
-4% -$109K
WEC icon
58
WEC Energy
WEC
$37.4B
$2.33M 0.62%
37,075
-1,749
-5% -$112K
PM icon
59
Philip Morris
PM
$298B
$2.33M 0.62%
20,962
-952
-4% -$111K
CCI icon
60
Crown Castle
CCI
$32.6B
$2.31M 0.62%
23,090
-1,294
-5% -$132K
BUD icon
61
AB InBev
BUD
$155B
$2.29M 0.61%
19,225
-1,444
-7% -$169K
ED icon
62
Consolidated Edison
ED
$41.6B
$2.28M 0.61%
28,246
-1,368
-5% -$113K
CYBR
63
DELISTED
CyberArk
CYBR
$2.25M 0.6%
+54,856
New +$2.32M
KHC icon
64
Kraft Heinz
KHC
$30.1B
$2.24M 0.6%
28,916
-607
-2% -$50.8K
PAYX icon
65
Paychex
PAYX
$39.4B
$2.21M 0.59%
36,907
-553
-1% -$31.6K
KMB icon
66
Kimberly-Clark
KMB
$35.6B
$2.17M 0.58%
18,426
-714
-4% -$87.2K
EQR icon
67
Equity Residential
EQR
$25.6B
$2.13M 0.57%
32,300
+302
+0.9% +$20.2K
VGR
68
DELISTED
Vector Group Ltd.
VGR
$2.1M 0.56%
159,622
-22,967
-13% -$298K
OTTR icon
69
Otter Tail
OTTR
$3.87B
$2.06M 0.55%
47,645
-1,407
-3% -$58.2K
MON
70
DELISTED
Monsanto Co
MON
$2.06M 0.55%
17,216
-10,342
-38% -$1.22M
INTC icon
71
Intel
INTC
$504B
$2.03M 0.54%
53,232
+968
+2% +$34.4K
ABBV icon
72
AbbVie
ABBV
$454B
$2.02M 0.54%
22,781
+1,076
+5% +$81.9K
CME icon
73
CME Group
CME
$91.9B
$1.98M 0.53%
14,573
-52
-0.4% -$6.57K
BXMT icon
74
Blackstone Mortgage Trust
BXMT
$2.78B
$1.97M 0.53%
63,554
-4,418
-6% -$137K
VOO icon
75
Vanguard S&P 500 ETF
VOO
$967B
$1.93M 0.51%
8,361
-127
-1% -$28.8K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.